Risk of ICU Admission and Related Mortality in Patients With Sodium-Glucose Cotransporter 2 Inhibitors and Dipeptidyl Peptidase-4 Inhibitors: A Territory-Wide Retrospective Cohort Study

The benefit of sodium-glucose cotransporter 2 (SGLT2) inhibitors in reducing the occurrence rate of adverse cardiac and renal outcomes in patients with type 2 diabetes has been well described in randomized trials. Whether this benefit extends to patients at the most severe end of the disease spectru...

Descripción completa

Detalles Bibliográficos
Autores principales: Ng, Pauline Yeung, Ng, Andrew Kei-Yan, Ip, April, Wu, Mei-Zhen, Guo, Ran, Yiu, Kai-Hang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Clinical Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335740/
https://www.ncbi.nlm.nih.gov/pubmed/37026864
http://dx.doi.org/10.1097/CCM.0000000000005869

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10335740/
https://www.ncbi.nlm.nih.gov/pubmed/37026864
http://dx.doi.org/10.1097/CCM.0000000000005869

Ejemplares similares